Skip to main content

Why this company's Durham outpost may benefit from $100M investment

Massachusetts-based gene therapy company bluebird bio – which is growing in Durham – has inked a $100 million deal for the development of treatments for cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.